- Cumberland Pharmaceuticals Reports First Quarter 2024 Financial Results & Company Update
- CUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2024 FINANCIAL RESULTS
- NEW REPORT SUPPORTS USE OF CALDOLOR® AS A STANDARD OF CARE ACROSS PATIENT POPULATIONS
- Cumberland Pharmaceuticals Reports Annual 2023 Financial Results
- CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2023 FINANCIAL RESULTS
More ▼
Key statistics
As of last trade, Cumberland Pharmaceuticals Inc (CPIX:NSQ) traded at 1.67, 17.61% above the 52 week low of 1.42 set on May 02, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.67 |
---|---|
High | 1.67 |
Low | 1.67 |
Bid | 1.55 |
Offer | 1.70 |
Previous close | 1.57 |
Average volume | 10.59k |
---|---|
Shares outstanding | 14.19m |
Free float | 7.95m |
P/E (TTM) | -- |
Market cap | 22.28m USD |
EPS (TTM) | -0.596 USD |
Data delayed at least 15 minutes, as of May 24 2024 14:43 BST.
More ▼